[go: up one dir, main page]

PL2687523T3 - Nowa pochodna fenylopirydyny i lek zawierający ją - Google Patents

Nowa pochodna fenylopirydyny i lek zawierający ją

Info

Publication number
PL2687523T3
PL2687523T3 PL12757676T PL12757676T PL2687523T3 PL 2687523 T3 PL2687523 T3 PL 2687523T3 PL 12757676 T PL12757676 T PL 12757676T PL 12757676 T PL12757676 T PL 12757676T PL 2687523 T3 PL2687523 T3 PL 2687523T3
Authority
PL
Poland
Prior art keywords
new
drug containing
phenylpyridine derivative
phenylpyridine
derivative
Prior art date
Application number
PL12757676T
Other languages
English (en)
Inventor
Toru Miura
Seiichi Sato
Hajime Yamada
Junya Tagashira
Toshiaki Watanabe
Ryohei Sekimoto
Rie Ishida
Hitomi Aoki
Tadaaki Ohgiya
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of PL2687523T3 publication Critical patent/PL2687523T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL12757676T 2011-03-14 2012-03-13 Nowa pochodna fenylopirydyny i lek zawierający ją PL2687523T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011055691 2011-03-14
PCT/JP2012/001709 WO2012124311A1 (ja) 2011-03-14 2012-03-13 新規なフェニルピリジン誘導体及びこれを含有する医薬
EP12757676.7A EP2687523B1 (en) 2011-03-14 2012-03-13 Novel phenylpyridine derivative and drug containing same

Publications (1)

Publication Number Publication Date
PL2687523T3 true PL2687523T3 (pl) 2016-06-30

Family

ID=46830402

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12757676T PL2687523T3 (pl) 2011-03-14 2012-03-13 Nowa pochodna fenylopirydyny i lek zawierający ją

Country Status (23)

Country Link
US (1) US9315493B2 (pl)
EP (1) EP2687523B1 (pl)
JP (1) JP5583841B2 (pl)
KR (1) KR101559307B1 (pl)
CN (1) CN103459380B (pl)
AU (1) AU2012227763B2 (pl)
BR (1) BR112013023038B1 (pl)
CA (1) CA2830043C (pl)
CY (1) CY1117348T1 (pl)
DK (1) DK2687523T3 (pl)
EA (1) EA026694B1 (pl)
ES (1) ES2562994T3 (pl)
HK (1) HK1189232A1 (pl)
HU (1) HUE028252T2 (pl)
MX (1) MX349697B (pl)
PH (1) PH12013501857A1 (pl)
PL (1) PL2687523T3 (pl)
PT (1) PT2687523E (pl)
RS (1) RS54666B1 (pl)
SG (1) SG193477A1 (pl)
TW (1) TWI525088B (pl)
WO (1) WO2012124311A1 (pl)
ZA (1) ZA201307333B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103690955B (zh) * 2013-12-27 2016-04-20 福州乾正药业有限公司 含有替格瑞洛的药物组合物及其制备方法和药物应用
WO2019117291A1 (ja) * 2017-12-14 2019-06-20 興和株式会社 医薬組成物
CN115138481B (zh) * 2022-07-06 2024-01-26 中南大学 一种将方铅矿、闪锌矿中的至少一种矿物与辉钼矿浮选分离的药剂和方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331165A (en) * 1976-09-03 1978-03-24 Iseki Kaihatsu Koki Continuous specific gravity meter
JPS5779456A (en) * 1980-11-06 1982-05-18 Fujitsu Ltd Voltage readout system by electron beam
JPS6211845A (ja) * 1985-07-10 1987-01-20 Sharp Corp 複写装置
US5472967A (en) 1991-02-20 1995-12-05 Synthelabo 4-pyrimidinone derivatives their preparation and their application in therapy
EP0514192A1 (en) * 1991-05-16 1992-11-19 Glaxo Group Limited Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups
CN1079223A (zh) * 1991-05-16 1993-12-08 格拉克索公司 苯并呋喃衍生物
IL102183A (en) 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
US5212177A (en) * 1991-12-16 1993-05-18 E. R. Squibb & Sons, Inc. Indole and benzimidazole-substituted dihydropyrimidine derivatives
JPH07179456A (ja) * 1993-12-21 1995-07-18 Nkk Corp アルキルベンゾフラン誘導体及びアンジオテンシンii拮抗剤
IT1273790B (it) 1994-02-18 1997-07-10 Guidotti & C Spa Labor Derivati eterociclici diazotati aventi attivita' aii antagonista
ZA200903867B (en) * 2006-11-24 2010-08-25 Takeda Pharmaceutical Heteromonocyclic compound and use thereof
EP2074117A2 (en) * 2006-11-24 2009-07-01 Takeda Pharmaceutical Company Limited Heteromonocyclic compound and use thereof
AU2007343139A1 (en) 2006-12-21 2008-07-17 Pfizer Products Inc. Compounds having both angiotensin II receptor antagonism and PPARy activating activities
WO2008096820A1 (ja) 2007-02-07 2008-08-14 Kyowa Hakko Kirin Co., Ltd. ビフェニル誘導体
JP4866901B2 (ja) 2007-02-07 2012-02-01 協和発酵キリン株式会社 3環系化合物
WO2008143262A1 (ja) 2007-05-21 2008-11-27 Takeda Pharmaceutical Company Limited 複素環化合物およびその用途
JPWO2010095462A1 (ja) * 2009-02-23 2012-08-23 興和株式会社 新規な3−(5−アルコキシピリミジン−2−イル)ピリミジン−4(3h)−オン構造を有する化合物及びこれを含有する医薬
US8664226B2 (en) * 2009-04-17 2014-03-04 Kowa Company, Ltd. Compound having 3-heteroarylpyrimidin-4-(3H)-one structure and pharmaceutical preparation containing same
TWI500611B (zh) * 2009-09-29 2015-09-21 Kowa Co 新穎苯基吡啶衍生物及含有該衍生物之醫藥

Also Published As

Publication number Publication date
EP2687523A4 (en) 2014-11-12
MX2013010553A (es) 2013-10-28
WO2012124311A8 (ja) 2013-05-10
CY1117348T1 (el) 2017-04-26
AU2012227763A8 (en) 2013-11-21
EP2687523B1 (en) 2016-01-06
AU2012227763B2 (en) 2016-01-14
AU2012227763A1 (en) 2013-10-24
WO2012124311A1 (ja) 2012-09-20
CA2830043A1 (en) 2012-09-20
JPWO2012124311A1 (ja) 2014-07-17
ES2562994T3 (es) 2016-03-09
KR101559307B1 (ko) 2015-10-12
HUE028252T2 (en) 2016-12-28
PT2687523E (pt) 2016-03-31
BR112013023038A2 (pt) 2016-12-13
TW201245180A (en) 2012-11-16
EA026694B1 (ru) 2017-05-31
EA201391314A1 (ru) 2014-02-28
KR20140008431A (ko) 2014-01-21
HK1189232A1 (zh) 2014-05-30
SG193477A1 (en) 2013-10-30
BR112013023038B1 (pt) 2019-09-03
CN103459380B (zh) 2015-07-15
NZ616158A (en) 2015-07-31
CN103459380A (zh) 2013-12-18
ZA201307333B (en) 2015-01-28
US9315493B2 (en) 2016-04-19
DK2687523T3 (en) 2016-03-14
EP2687523A1 (en) 2014-01-22
JP5583841B2 (ja) 2014-09-03
CA2830043C (en) 2018-06-05
TWI525088B (zh) 2016-03-11
AU2012227763A2 (en) 2013-11-14
MX349697B (es) 2017-08-09
US20140011823A1 (en) 2014-01-09
RS54666B1 (en) 2016-08-31
PH12013501857A1 (en) 2013-10-14

Similar Documents

Publication Publication Date Title
CO6910189A2 (es) Derivado heterociclico y farmacéutico
IL228925A0 (en) Benzothiazole compounds and their pharmaceutical use
DK2709667T3 (da) Bio-orthogonal lægemiddelaktivering
EP2699293A4 (en) SELF-INJECTOR APPARATUS
BR112013020613A2 (pt) autoinjetor
DK3202760T3 (da) Pegylerede lipider og deres anvendelse til lægemiddelfremføring
DK2768559T3 (da) Lægemiddelindgivelsesanordning
PT2793578T (pt) Derivados de sulfureto de trifluoroetilo n-arilamidinasubstituídos como acaricidas e inseticidas
EP2688642A4 (en) neurostimulator
EP2768942A4 (en) INTRA-CELLULAR ADMINISTRATION
IL230838A0 (en) Pharmaceutical compositions
EP2709645A4 (en) ENHANCED PEPTIDE PHARMACEUTICAL AGENTS
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
DK3384944T3 (da) Autoinjektor
BR112014012778A8 (pt) embalagem de cateter
EP2799101A4 (en) MEDICATION INJECTION DEVICE
CO6990717A2 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
BR112013014644A2 (pt) composição farmacêutica e complexo
DK2740504T3 (da) Lægemiddelfremføringsanordning
CO6940426A2 (es) Formulaciones farmacéuticas
BR112014009319A2 (pt) compostos farmacêuticos
EP2883547A4 (en) MEDICINE
BR112014015885A2 (pt) preparação farmacêutica
HUE039907T2 (hu) Gyógyszer-szállító technológia
EP2558094A4 (en) PYRIDONE DERIVATIVES